Top Investor Advisor Urges TELUS International Investors: Don’t Miss the Deadline in the Securities Class Action Lawsuit! 🚨

Important Information for TELUS International (TIXT) Investors: Rosen Law Firm Reminds of Class Action Lawsuit and Lead Plaintiff Deadline New York, NY – Rosen Law Firm, a global investor rights law firm, alerts investors of TELUS International, Inc. (TIXT) to take notice of a class action lawsuit that has been filed. The lawsuit was initiated…

Read More

Rosen, a Leading National Law Firm, Offers Encouragement to TransMedics Group, Inc. in Their Business Ventures

Important Information for TransMedics Group, Inc. Securities Purchasers: Deadline Reminder for Securities Class Action Rosen Law Firm, a leading global investor rights law firm, would like to remind investors who purchased securities of TransMedics Group, Inc. (NASDAQ: TMDX) between February 28, 2023, and January 10, 2025, both dates inclusive (the “Class Period”), that they have…

Read More

NeuroPace Completes Public Offering, Selling Additional Shares with Full Underwriter Option: A Look at the Details

NeuroPace’s Successful Public Offering: A New Chapter in Neurotechnology Mountain View, California – NeuroPace, Inc., a pioneering neurotechnology company, announced on February 18, 2025, the successful completion of its underwritten public offering. The offering consisted of 7,475,000 shares of common stock, with an additional 975,000 shares sold through the underwriters’ option. These shares were offered…

Read More

Fidus Investment Corporation Announces First Quarter 2025 Dividend Payment

Fidus Investment Corporation Announces First Quarter 2025 Dividends EVANSTON, Ill., February 18, 2025 – Fidus Investment Corporation (NASDAQ: FDUS) (“Fidus” or the “Company”), a leading provider of customized financing solutions, recently announced that its Board of Directors declared dividends for the first quarter of 2025. The dividends consist of a base dividend of $0.43 per…

Read More

ANI Pharmaceuticals: Unveiling Fourth-Quarter and Full-Year 2024 Financial Results – A Heartfelt Invitation to Join the Journey of Transparency on February 28, 2025, at 8:00 a.m. ET

ANI Pharmaceuticals to Release Fourth Quarter and Full Year 2024 Financial Results Princeton, N.J., Feb. 18, 2025 – ANI Pharmaceuticals, Inc. (ANI), a leading specialty pharmaceutical company, has announced that it will release its financial results for the fourth quarter and full year ended December 31, 2024, on Friday, February 28, 2025. The announcement was…

Read More

Silver Lake Nears Deal for Majority Stake in Intel’s Altera Unit: A New Chapter in Tech Mergers?

Silver Lake’s Potential Acquisition of Intel’s Altera: A Game-Changer in the Tech Industry In an exciting turn of events, buyout firm Silver Lake is reportedly in advanced talks to acquire a significant stake in Intel’s programmable chip business, Altera, according to reliable industry sources. This potential deal, if finalized, could have far-reaching implications for both…

Read More